Last reviewed · How we verify
NCT06179784
Personalising Psychotherapy for Chronic Primary Pain Using Network Analysis
NA trial testing Cognitive Behaviour Therapy including third-wave in Chronic Primary Pain in 12 participants. Completed in 8 August 2025.
8 August 2025
Quick facts
| Lead sponsor | Prof. Dr. Julia Glombiewski |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 17 November 2023 |
| Primary completion | 8 August 2025 |
| Estimated completion | 8 August 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Cognitive Behaviour Therapy including third-wave
Conditions studied
- Chronic Primary Pain — all drugs for Chronic Primary Pain →
Sponsor
Prof. Dr. Julia Glombiewski
Who can join
18 and older, any sex, with Chronic Primary Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this single case experimental design study with multiple baselines is to use network analysis to personalise cognitive behaviour therapy for chronic primary pain (CPP) and base the selection of individual treatment targets and interventions on data to avoid cognitive biases of the clinicians. The main questions it aims to answer are: * Is the study procedure accepted by and feasible for CPP patients as well as their therapists? * Does the personalised psychotherapy with databased clinical decisionmaking lead to significant improvement? Participants will go through several study phases: * Pretest and informational meeting with study management * Baseline 1: answering a questionnaire six times a day for 21 days in daily life on their mobilephone (EMA); this data will be used for the calculation of a network for each participant, that in turn will be used to select the treatment target and according treatment intervention as suggested by an algorithmic decisiontool * Probatory therapy phase: three weekly sessions with therapist; questionnaire three times a week * Baseline 2: questionnaire three times a week * Therapy phase: up to ten sessions with therapist; questionnaire three times a week * Post phase: posttest, two weeks of three weekly assessments, then another 21 days EMA; two monthly booster sessions with therapist * Follow-up: posttest and meeting with study management
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
How to personalise cognitive-behavioural therapy for chronic primary pain using network analysis: study protocol for a single-case experimental design with multiple baselines.
Hofmann VE, Glombiewski JA, Kininger F, Scholten S. · · 2024 · cited 2× · PMID 39627123 · DOI 10.1136/bmjopen-2024-089319
Verify or expand the search:
- PubMed search for NCT06179784
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Primary Pain
Currently open trials in the same condition.
- NCT05860816 — Facilitators and Barriers in Neuroscience-based Pain Education Programmes in Primary Care Physiotherapy · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06179784 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prof. Dr. Julia Glombiewski
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06179784.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing